Skip to main content

Table 1 Characteristics of patients with DRP (n = 185)

From: Clinical, economic and organizational impact of pharmacist interventions on injectable antineoplastic prescriptions: a prospective observational study

Patients characteristics

n (%)

Age, mean (SD)

63.5 (13.7)

Sex (male)

100 (54.1)

Diagnosis

Solid tumor

150 (81.1)

  Breast Cancer

26 (14.1)

  Colorectal cancer

26 (14.1)

  Non-small cell lung cancer

22 (11.9)

  Head and neck cancer

21 (11.4)

  Ovarian cancer

10 (5.4)

  Cancer of the pancreas

8 (4.3)

  Neuroendocrine cancer

8 (4.3)

  Bladder cancer

5 (2.7)

  Small cell lung cancer

5 (2.7)

  Cervical cancer

4 (2.2)

  Oesophageal cancer

4 (2.2)

  Glioma

2 (1.1)

  Sarcoma

2 (1.1)

  Thymus carcinoma

2 (1.1)

  Anal cancer

1 (0.5)

  Astrocytoma

1 (0.5)

  Biliary cancer

1 (0.5)

  Gastric cancer

1 (0.5)

  Prostate cancer

1 (0.5)

Hematologic disease

35 (18.9)

  Non Hodgkin lymphoma

11 (6.0)

  Multiple myeloma

8 (4.3)

  Acute leukemia

7 (3.9)

  Hodgkin lymphoma

3 (1.6)

  Myelomonocytic leukemia

2 (1.1)

  Chronic lymphocytic leukemia

1 (0.5)

  Glanzmann thrombasthenia

1 (0.5)

  Hairy cell leukemia

1 (0.5)

  Idiopathic thrombocytopenic purpura

1 (0.5)